Bart Rijnders
Impact in
- Emergency Medical Services top 0.05%
- Central Venous Catheters and Hemodialysis
- Infectious Diseases top 0.2%
- Antifungal resistance and susceptibility
- Antimicrobial Resistance in Staphylococcus
Papers in
-
- Antifungal resistance and susceptibility 51
- HIV/AIDS drug development and treatment 27
- HIV/AIDS Research and Interventions 17
- COVID-19 Clinical Research Studies 14
- SARS-CoV-2 and COVID-19 Research 13
- Virology 21
- HIV Research and Treatment 21
- Co-authors
- Donald E. CravenEmilio BouzaIssam RaadMichael AllonNaomi P. O’GradyLeonard A. MermelPatricia M. FlynnDavid K. Warren
- Journals
- Clinical Infectious Diseases (20 papers)Journal of Antimicrobial Chemotherapy (12 papers)AIDS (8 papers)Journal of Clinical Microbiology (7 papers)Clinical Microbiology and Infection (5 papers)
- Partner nations
- NetherlandsBelgiumUnited States
In The Last Decade
Bart Rijnders
139 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Emergency Medical Services 1.8k
- Infectious Diseases 4.1k
- Applied Microbiology and Biotechnology 322
- Clinical Biochemistry 705
- Epidemiology 3.4k
Countries citing papers authored by Bart Rijnders
This map shows the geographic impact of Bart Rijnders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Rijnders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Rijnders more than expected).
Fields of papers citing papers by Bart Rijnders
This network shows the impact of papers produced by Bart Rijnders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Rijnders. The network helps show where Bart Rijnders may publish in the future.
Co-authors
The 25 scholars most cited alongside Bart Rijnders, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 10 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 13 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 15 | |
| 8 | 2022 | 56 | |
| 9 | 2022 | 16 | |
| 10 | 2022 | 28 | |
| 11 | 2022 | 6 | |
| 12 | Potent neutralizing antibodies for severe COVID-19: A randomized clinical trial | 2021 | 1 |
| 13 | 2021 | 20 | |
| 14 | 2020 | 21 | |
| 15 | 2020 | 231 | |
| 16 | 2016 | 15 | |
| 17 | PCR-based detection of A. fumigatus cyp51A mutations on bronchoalveolar lavage can readily predict azole treatment failure. A multi-center validation study in 201 hematology patients with suspected invasive aspergillosis | 2015 | 1 |
| 18 | Diagnostics performance of galactomannan antigen in cerebral spinal fluid in patients with cerebral aspergillosis | 2015 | 0 |
| 19 | 2015 | 11 | |
| 20 | Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America Hit paper breakdown → | 2009 | 2439 |
About Bart Rijnders
Bart Rijnders is a scholar working on Infectious Diseases, Virology, Hepatology, Epidemiology and Small Animals, having authored 144 papers that have together received 7.2k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (51 papers), Fungal Infections and Studies (39 papers), HIV/AIDS drug development and treatment (27 papers), HIV Research and Treatment (21 papers), Hepatitis C virus research (19 papers), HIV/AIDS Research and Interventions (17 papers), COVID-19 Clinical Research Studies (14 papers) and SARS-CoV-2 and COVID-19 Research (13 papers). The work is most often cited by research in Emergency Medical Services (1.8k citations), Infectious Diseases (4.1k citations), Applied Microbiology and Biotechnology (322 citations), Clinical Biochemistry (705 citations) and Epidemiology (3.4k citations). Bart Rijnders has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include Donald E. Craven, Emilio Bouza, Issam Raad, Michael Allon, Naomi P. O’Grady, Leonard A. Mermel, Patricia M. Flynn, David K. Warren, Robert J. Sherertz and Paul E. Verweij. Their work appears in journals such as Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy, AIDS, Journal of Clinical Microbiology and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.